HOME >> BIOLOGY >> NEWS
Echinacea Symposium Presents New Research On Chernobyl Victims

The results from a long-term clinical study in the Ukraine on the use of Echinacea to treat victims of the Chernobyl disaster is among the new studies to be presented at the 1999 International Echinacea Symposium June 3-5 in Kansas City, MO.

Dr. Victoriya F. Pochernyayeva, a leading researcher from Ukraine and the former Soviet Union, will review the results of her long-term studies including:

  • An analysis of how effectively Echinacea purpurea, consumed as a food additive in fruit juices and other non-alcoholic and alcoholic drinks, protects people who are exposed to radiation. Based on her findings, Dr. Pochernyayeva recommends ways Echinacea purpurea food additives can be used most effectively to safeguard a population that is facing high levels of radiation exposure;
  • A study of how Echinacea purpurea can protect the male reproductive system from the effects of radiation;
  • A study of how effectively Echinacea purpurea can protect organs and tissues from radiation damage.

The world's leading Echinacea researcher, Dr. Rudolf Bauer, is the keynote speaker. Dr. Bauer, professor at the Institute of Pharmaceutical Biology, University of Dusseldorf, has published more than 100 research papers and has edited a book on Echinacea. He's currently researching the quality aspects of Echinacea preparations, constituents and pharmacological activity of Echinacea species.

The event is hosted by the American Herbal Products Association. Sponsors include Nature's Way, Botanicals International, Bioforce USA, Finzelberg North America, Rexall Sundown, Indena USA, and Plantation Medicinals.

Who: Some 150 researchers, scientists and other professionals from the herbal industry.

What: 1999 International Echinacea Symposium

Where: Ritz-Carlton, Kansas City, MO.

When: June 3-5, 1999

Why: To present the latest clinical research, and learn about the
'"/>

Contact: Brian Ruberry
br@rubcomm.com
301-947-1662
American Herbal Products Association
11-May-1999


Page: 1 2 3

Related biology news :

1. NIH funds botanical center in Iowa to study health effects of Echinacea and St. Johns wort
2. Worlds Leading Echinacea Researchers To Examine Latest Scientific Findings On "Natures Gentle Antibiotic"
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
6. Health of worlds sea lions the focus of Wakefield Symposium
7. Chemical signals health of brain cells Symposium
8. Final Alert: 16th EORTC NCI AACR Symposium
9. 16th EORTC NCI AACR Symposium
10. Symposium to tackle questions of genetic engineering and biodiversity
11. Fostering Diversity in the Sciences Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Echinacea Symposium Presents New Research Chernobyl Victims

(Date:4/18/2014)... Protecting wildlife while feeding a world population predicted ... a holistic approach to conservation that considers human-altered ... , Wildlife and the natural habitat that supports ... a world where at least three-quarters of the ... the rest is vulnerable to human-caused impacts such ...
(Date:4/18/2014)... led by a University of California, Riverside professor of ... Department of Defense grant to uncover fundamental design rules ... predictable design of light-weight, tough and strong advanced materials ... and animals, including the mantis shrimp, toucan and bamboo. ... over millions of years and coming up with design ...
(Date:4/17/2014)... of stem cell therapies to cure a variety of ... populations based on cell surface markers. Researchers from the ... is highly expressed in a type of stem cells ... in an article in BioResearch Open Access , ... The article is available free on the ...
Breaking Biology News(10 mins):Stanford researchers rethink 'natural' habitat for wildlife 2Stanford researchers rethink 'natural' habitat for wildlife 3Stanford researchers rethink 'natural' habitat for wildlife 4Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: